Isodiol International Inc.
ISOLF
$0.00
$0.000.00%
| Weiss Ratings | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 31.77 | |||
| Price History | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.01% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 20, 2024 | |||
| 52-Week High Price (Date) | Jul 02, 2024 | |||
| Valuation | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 128.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -0.11 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 49.14M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 409 4409 | |||
| Address | 200 Granville Street Vancouver, BC V6C 1S4 | |||
| Website | isodiol.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -91.43% | |||
| Profit Margin | -94.99% | |||
| Management Effectiveness | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 5.58M | |||
| Total Revenue (TTM) | 5.58M | |||
| Revenue Per Share | $0.11 | |||
| Gross Profit (TTM) | 1.48M | |||
| EBITDA (TTM) | -4.90M | |||
| EBIT (TTM) | -5.10M | |||
| Net Income (TTM) | -5.30M | |||
| Net Income Avl. to Common (TTM) | -5.30M | |||
| Total Revenue Growth (Q YOY) | -85.69% | |||
| Earnings Growth (Q YOY) | 95.55% | |||
| EPS Diluted (TTM) | -0.11 | |||
| EPS Diluted Growth (Q YOY) | 96.38% | |||
| Balance Sheet | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.16M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 5.18M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -319.40K | |||
| Current Ratio (Q) | 1.165 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 8.50M | |||
| Total Current Liabilities (Q) | 4.45M | |||
| Total Debt (Q) | 4.51M | |||
| Total Liabilities (Q) | 8.82M | |||
| Total Common Equity (Q) | -319.40K | |||
| Cash Flow | ISOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.29M | |||
| Cash from Financing (TTM) | -2.50M | |||
| Net Change in Cash (TTM) | -150.90K | |||
| Levered Free Cash Flow (TTM) | 3.59M | |||
| Cash from Operations (TTM) | 1.93M | |||
